| Shareholder | |||
|---|---|---|---|
| Robert Taylor NELSENNon-Executive Director | 11.89% | 125.09M | |
| Bybee Clinton Whitewood | 11.89% | 125.09M | |
| Crandell Keith Lawrence | 11.89% | 125.09M | |
| Robert Taylor NELSENNon-Executive Director | 11.87% | 125.24M | |
| Venrock Management V, LLC | 9.84% | 103.48M | |
| Venrock Management V, LLC | 8.99% | 94.96M | |
| THE CORE TRUST COMPANY LIMITED | 7.99% | 84.40M | |
| Li CHENExecutive Director | 7.64% | 80.74M | |
| Hong Jane Xingfang | 7.64% | 80.74M | |
| WuXi PharmaTech Healthcare Fund I L.P. | 7.02% | 74.03M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
This page shows the major shareholders of HUA MEDICINE-B (02552) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

